| Pfizergate: Transparency or Privacy Protection?

Recent investigation into the purchase of Pfizer vaccines by the EU has revealed the involvement of Ursula von der Leyen, President of the European Commission, raising questions about transparency and accountability. With the interconnection of several cases, including allegations of undisclosed agreements and legal actions, attention to negotiation processes and financial management within the Commission is increasing. The outcomes of these investigations may influence public trust and future leadership of the EU, highlighting the delicate balance between transparency and privacy protection. Žiga Faktor, Deputy Director and Head of the Brussels Office of the EUROPEUM Institute, offered a commentary for

Show more | Ursula von der Leyen and Pfizergate

European Commission President Ursula von der Leyen faces charges related to the purchase of Covid-19 vaccines from Pfizer. The first information came from the The New York Times, which has subpoenaed European Commission documents relating to the negotiations for the purchase of the vaccines. Žiga Faktor, deputy director and head of the EUROPEUM Institute's Brussels office, commented on the case for

Show more

Právo | Von der Leyen wants to continue leading the EU

As expected, Ursula von der Leyen has confirmed her interest in continuing as President of the European Commission. Since her arrival, she has faced crises such as Brexit, the global pandemic, the battle over vaccines and the Russian invasion of Ukraine. The announcement of her candidacy was analysed by Viktor Daněk, deputy director of the EUROPEUM institute, in Deník Právo.

Show more

PRAVDA: Heger has a proposal for the European Union on how to distribute vaccines

Our director Vladimír Bartovic commented for the Slovak daily Pravda on Slovakia's approach to the realization of the EU Recovery Plan.

Show more

"Europe will be made through crises": the limits to the Monnet-Schuman approach to European construction

Rose Hartwig-Peillon analyses Monnet-Schuman's saying regarding to European construction through crises in view to pandemic of covid-19, vaccines and European recovery plan.

Show more

TA3: Summit of the EU leaders ended. What did negotiations bring?

The director of the EUROPEUM Institute for European Policy Vladimír Bartovic was a guest on Slovak news television TA3. In the broadcast he commented on a summit of the EU leaders, which took place on 25-26 March. The debate particularly covered the rate of vaccination in Europe and potential controls of vaccines exports.

Show more

TA3: Summit of EU leaders begins, vaccination and vaccine exports will be discussed

Meetings of the prime ministers and presidents of the EU member states began in Brussels. The main topic is the pandemic, vaccination strategies, and delayed delivery of vaccines. US President Joe Biden was also invited to the discussion. What outcome can be expected? This was presented by our associate research fellow Zuzana Stuchlíková.

Show more

INVITATION: Perceptions of EU in Central Europe amid COVID-related crisis

We would like to invite you to the webinar Perceptions of the EU in Central Europe amid COVID-related crisis organized by the Think Visegrad platform which brings together 8 think-tanks from Central Europe.

Show more

ČRo Plus: In the Western Balkans, there is a risk of increased influence of foreign participants

The director of our institute, Vladimir Bartovic, commented on the current situation in the Western Balkans. Interest in the countries is declining on the part of the EU due to the COVID-19 crisis, when the countries of the Western Balkans have to procure vaccines themselves.

Show more

Rádio Slovensko: Slovak government agreed to purchase the Russian unregistered vaccine Sputnik V

Director of the EUROPEUM Institute for European Policy Vladimír Bartovic was a guest at today’s broadcast of Rádio Slovensko, where he commented on the decision made by the Slovak government led by Igor Matovič regarding the purchase of Russian vaccine Sputnik V. Vaccines, which are currently being used in the EU are properly registered, whereas the Russian one is not. Nevertheless, opinions on the vaccine differs broadly.

Show more

EUROPEUM Institute for European Policy
Staroměstské náměstí 4/1
Prague 1 - Staré Město
110 00

tel.: +420 212 246 552